STIMULATING CAPACITY OF FRESH AND CULTURED HUMAN LEUKEMIC LYMPHOID AND MYELOID CELLS IN ONE-WAY MIXED LYMPHOCYTE-REACTION
- 1 January 1977
- journal article
- research article
- Vol. 33 (4) , 543-551
Abstract
Fresh normal peripheral blood B [bone marrow-derived] lymphocytes possess a strong stimulating capacity, while fresh thymus cells or fresh peripheral T [thymus-derived] lymphocytes possess a weak, but significant stimulating capacity on allogeneic lymphocytes in one-way mixed lymphocyte reaction. Fresh leukemic T lymphoid cells from patients with T-cell ALL [acute lymphocytic leukemia] or T-cell CLL [chronic lymphocytic leukemia] exert little or no stimulation on allogeneic lymphocytes. Fresh leukemic B lymphoid cells from patients with B-cell CLL or B-cell HCL [hairy cell leukemia] exert a lesser stimulation on allogeneic lymphocytes as compared to that of normal B lymphocytes. Leukemic myeloblasts from patients with AML [acute myelogenous leukemia] or pH1(+) CML[chronic myelogenous leukemia]-BP exert significantly higher stimulation than leukemic lymphoid cells in one-way mixed lymphocyte reaction (P < 0.05). Cultured leukemic T lymphoid [human] cells (MOLT-4) possess no stimulating capacity, cultured leukemic B lymphoid [human] cells (BALM-2) possess a moderate degree of stimulating capacity and cultured leukemic, possibly myeloid, [human] cells (NALM-1 and K562) possess vigorous stimulation on allogeneic lymphocytes. The stimulating capacity of NALM-1 or K562 cells is significantly higher than that of BALM-2 cells (P < 0.01 or P < 0.05, respectively) and that of MOLT-4 cells (P < 0.001). The stimulating capacity of leukemic T or B lymphoid cells may be completely or partially lost during the process of leukemogenesis. It is not known whether the stimulating capacity of leukemic myeloblasts, which is very strong on allogeneic lymphocytes, may be modified during the process of leukemogenesis.This publication has 17 references indexed in Scilit:
- T and B lymphocytes. Exclusive role as responders and stimulators in human one-way mixed lymphocyte reaction.1976
- T- and B-Lymphocytes in Chronic Lymphocytic Leukemia: Correlation With Clinical and Immunologic Status of the Disease2JNCI Journal of the National Cancer Institute, 1976
- Terminal Deoxynucleotidyl Transferase Activity in Human Leukemic Cells and in Normal Human ThymocytesNew England Journal of Medicine, 1975
- Disparity of Mixed Lymphocyte Reactivity to Cultured Cells of Human T and B Lymphoid Lines2JNCI Journal of the National Cancer Institute, 1975
- Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome.1975
- Failure of Cultured Human T-Cell Lymphoid Lines to Stimulate in Mixed Leukocyte CultureJNCI Journal of the National Cancer Institute, 1974
- Stimulatory capacity of human T and B lymphocytes in the mixed leukocyte cultureNature, 1974
- A unique 'leukaemic' T lymphoid cell line: absence of stimulating effect in mixed lymphocyte reaction. Lack of MLR-S in leukaemic T lymphoid cells.1973
- “Antigenic” disparity between cultured lymphoid cells and autologous lymphocytesThe American Journal of Medicine, 1972
- ENHANCED IMMUNE RESPONSE TO LEUKÆMIAThe Lancet, 1971